# Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

> **NCT03440879** · NA · TERMINATED · sponsor: **Norwegian School of Sport Sciences** · enrollment: 23 (actual)

## Conditions studied

- Prostate Cancer
- Resistance Exercise
- Androgen Deprivation Therapy

## Interventions

- **DRUG:** Zoladex

## Key facts

- **NCT ID:** NCT03440879
- **Lead sponsor:** Norwegian School of Sport Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-21
- **Primary completion:** 2023-03-02
- **Final completion:** 2023-03-02
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Low recruitment rate
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03440879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03440879, "Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03440879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*